Viewing Study NCT00241657



Ignite Creation Date: 2024-05-05 @ 12:05 PM
Last Modification Date: 2024-10-26 @ 9:20 AM
Study NCT ID: NCT00241657
Status: COMPLETED
Last Update Posted: 2005-12-15
First Post: 2005-10-17

Brief Title: Immune Responses to BCG Vaccination in Malawi and the UK
Sponsor: London School of Hygiene and Tropical Medicine
Organization: London School of Hygiene and Tropical Medicine

Study Overview

Official Title: None
Status: COMPLETED
Status Verified Date: 2002-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: BCG vaccination has been found to provide greater protection against TB in the UK than in Malawi This study compares immune responses in BCG-vaccinated and unvaccinated teenagers and young adults in Malawi and in the UK
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None